Organization
Shire Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Shire Pharmaceuticals, Inc.
... to 2013, Ms. Melincoff was Senior Vice President of Business Development at Shire Pharmaceuticals. Additionally, from 2010 to 2013, she led the company's Strategic Investment ...
... BP and Smith & Nephew, companies as diverse as engineering group Weir, Shire Pharmaceuticals, estate agent Foxtons and betting company Paddy Power Betfair were also ...
... he was head of U.S. sales for the rare disease unit of Shire Pharmaceuticals, where he also served as U.S. sales director for its renal ...
... it has entered into agreements with Teva Pharmaceutical Industries Ltd. (Teva) and Shire LLC, an indirect subsidiary of Shire plc, to acquire the rights to ...
... moves to oppose executive pay deals, including the majority of investors at Shire pharmaceuticals failing to support a 25% rise for its chief executiveThere was ...
... forced to abandon potential share awards for its top management team and Shire Pharmaceuticals failing to get a majority of investors to support its pay ...
... be revolts against remuneration policies at several major companies including drugs firm Shire Pharmaceuticals, and engineering group Weir. My colleague Jill Treanor explains: The votes ...
... they begin the focus is on FTSE 100 companies - such as Shire Pharmaceuticals, building materials business CRH, Barclays and fund manager Schroders - and ...
... their attention to HSBC's annual meeting on Friday and next week to Shire Pharmaceuticals, which handed its chief executive, Flemming Ørnskov, a 25% rise in ...
... clinical development programs and most recently was director of clinical programs at Shire Pharmaceuticals. Mr. Kiernan has more than 20 years of experience in pharmaceuticals ...
... held positions of increasing responsibility in the Pharmaceutical Sciences, most recently at Shire Pharmaceuticals, where his teams were responsible for the Pharmaceutical Development of several ...
... to joining Amplyx, she served as vice president of regulatory affairs at Shire Pharmaceuticals and held the same position at Lumena Pharmaceuticals prior to its ...
... Rosenberg, a biopharmaceutical legal executive with strong commercial experience, most recently as Shire Pharmaceuticals' Head of U.S. Legal, has been appointed General Counsel and Corporate ...
... Commercial Alnylam Pharmaceuticals Jay Greissing Director, U.S. Government Relations and Public Policy Shire Pharmaceuticals Timothy J. Foster, Sr. Senior Director, Client Engagement OptumRx, a division ...
... explores activities, results and potentials of top companies, especially these firms: · Shire Pharmaceuticals. · Allergan · Janssen Biotech · AbbVie With our new study ...
... RARE disease drug maker Shire Pharmaceuticals is preparing to announce a £22bn acquisition of US peer Baxalta ...
... Walsh, MD PhD, Boston Children's Hospital Albert Seymour, PhD, Head of Research, SHIRE Pharmaceuticals Nina F. Schor, MD, PhD, Golisano Children's Hospital, University of Rochester ...
... years of regulatory strategy and submissions experience at major pharmaceutical firms, including Shire and Pfizer. Both individuals will report to Marinus's Chief Medical Officer, Albena ...
... be ashamed to talk about it. These ads were paid for by Shire Pharmaceuticals, the same company that makes the amphetamine Adderall. But Adderall has ...
Want to see the full history on Shire Pharmaceuticals, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial